April 5, 2022 – The Biden administration on Tuesday announced a major federal effort to better understand, record, and manage the long -term effects of COVID.
The National Research Action Plan on Long-term COVID will bring together experts from a variety of departments, including the Department of Defense and the Department of Veterans Affairs, expand long-term COVID health facilities and increase research into hospitals. symptoms of the disease persist long after the disease.
“We will work with education, industry, state and local partners to better understand the longevity of COVID,” Health and Human Services Secretary Xavier Becerra said at a White House press conference on Tuesday. “We have to work as hard as we can to make sure America doesn’t leave.”
The project will be built on the RECOVER Initiative, a $ 1.15 billion initiative announced last year to study long -term COVID.
The COVID-19 response group also announced Tuesday that the United States will transmit tens of millions of pediatric coronavirus infections to other countries. More than 20 countries have applied for donations, the company said.
The U.S. has supplied more than 500 million tons of corn to 114 countries.
Currently, COVID-19 numbers continue to fall. CDC Director Rochelle Walensky, MD, reported that the average number of cases per day is down 4% this week to 25,000; hospitals fell 17% to 1,400 per day; and daily mortality below 570 per day, a decrease of about 17%.
The new government estimates of Omicron’s subvariant BA.2 currently account for 72% of the country’s diversity, he said.
Clinical physician Anthony Fauci, MD, said the new data supported the effectiveness of a second booster among people 50 and over – a move approved by the FDA and CDC in the United States. last week.
“The effectiveness of the first booster effect we’ve seen in a while, and the growing body of evidence suggesting a second course of illness could reverse the effect of vaccine for some populations. “he said.
Fauci reported data from an Israeli study of more than 1 million people 60 and over, which showed a new booster effect after 4 months that lowered the number of patients. twice as much and lower the incidence of disease more than four times.
A study from Israeli scientists reported that from half a million people 60 and over, the second booster after 4 months brought a 78% reduction in deaths, compared to with those who received only the initial increase.